{"id":"https://openalex.org/W61315535","doi":null,"title":"Low-dose schema of isotretinoin in acne vulgaris.","display_name":"Low-dose schema of isotretinoin in acne vulgaris.","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W61315535","mag":"61315535","pmid":"https://pubmed.ncbi.nlm.nih.gov/15018017"},"language":"en","primary_location":{"id":"pmid:15018017","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15018017","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology research","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028008257","display_name":"Ioanna Mandekou\u2010Lefaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160454","display_name":"Hospital Venereal and Skin Diseases Thessaloniki","ror":"https://ror.org/055bcma36","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210160454"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"I Mandekou-Lefaki","raw_affiliation_strings":["State Hospital for Skin and Venereal Diseases, Thessaloniki, Greece. drfsn@yahoo.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"State Hospital for Skin and Venereal Diseases, Thessaloniki, Greece. drfsn@yahoo.com","institution_ids":["https://openalex.org/I4210160454"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014763881","display_name":"Florentina Silvia Delli","orcid":"https://orcid.org/0000-0002-2344-7118","observed_orcids":["https://orcid.org/0000-0002-2344-7118"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Delli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073717264","display_name":"A Teknetzis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Teknetzis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091818892","display_name":"R Euthimiadou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Euthimiadou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5085143644","display_name":"George Karakatsanis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Karakatsanis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0557,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.73568036,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"23","issue":"2-3","first_page":"41","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/isotretinoin","display_name":"isotretinoin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/low-dose-regimen","display_name":"low-dose regimen","score":0.8349999785423279},{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.9779999852180481},{"id":"https://openalex.org/keywords/papulopustular-acne","display_name":"papulopustular acne","score":0.8889999985694885},{"id":"https://openalex.org/keywords/nodulocystic-acne","display_name":"nodulocystic acne","score":0.9890000224113464},{"id":"https://openalex.org/keywords/acne-scars","display_name":"acne scars","score":0.7089999914169312},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.609000027179718},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.8240000009536743},{"id":"https://openalex.org/keywords/total-dose","display_name":"total dose","score":0.6449999809265137},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.5410000085830688}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9165781736373901},{"id":"https://openalex.org/C2776285725","wikidata":"https://www.wikidata.org/wiki/Q287029","display_name":"Isotretinoin","level":3,"score":0.9141186475753784},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.8354007005691528},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7637763619422913},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7343461513519287},{"id":"https://openalex.org/C2778847519","wikidata":"https://www.wikidata.org/wiki/Q7133233","display_name":"Papulopustular","level":4,"score":0.674903929233551},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6029443144798279},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5051446557044983},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39252376556396484},{"id":"https://openalex.org/C2778081122","wikidata":"https://www.wikidata.org/wiki/Q831530","display_name":"Rosacea","level":3,"score":0.13103532791137695}],"mesh":[{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015474","descriptor_name":"Isotretinoin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015474","descriptor_name":"Isotretinoin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015474","descriptor_name":"Isotretinoin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D015474","descriptor_name":"Isotretinoin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15018017","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15018017","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology research","raw_type":"Clinical Trial"},{"id":"mag:61315535","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15018017","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2599638892","https://openalex.org/W2036922943","https://openalex.org/W2065245096","https://openalex.org/W3093766962","https://openalex.org/W2094262043","https://openalex.org/W2783055721","https://openalex.org/W1794769932","https://openalex.org/W1586425912","https://openalex.org/W4367184285","https://openalex.org/W1969067090"],"abstract_inverted_index":{"In":[0],"severe":[1,23],"papulopustular":[2],"and":[3,50,73,86,96,102,152,157,162,193,204,249],"in":[4,80,116,246],"nodulocystic/conglobate":[5],"acne,":[6,24,148],"oral":[7],"isotretinoin":[8,54,79,238],"is":[9,15],"the":[10,58,70,81,171,216,220,243],"treatment":[11,59,82,111],"of":[12,37,41,48,53,60,64,75,78,83,104,113,124,133,147,164,170,191,195,219,237],"choice.":[13],"It":[14],"also":[16],"required":[17],"for":[18,57,186],"patients":[19,93],"with":[20,89,99,129,142],"moderate":[21],"to":[22,30,68,144,154,180,241],"especially":[25],"when":[26],"acne":[27,84,105],"scars":[28],"start":[29],"occur":[31],"A":[32],"new":[33],"therapeutic":[34,71,235],"approach":[35],"consists":[36],"a":[38,45,117,121,130,206,225],"low-dose":[39,51,88,172,198,221],"regimen":[40,236],"isotretinoin.":[42],"We":[43,223],"performed":[44],"comparative":[46],"study":[47,66],"high-":[49],"schemas":[52],"per":[55,127,136],"os":[56],"acne.":[61],"The":[62,166,176,197],"purpose":[63],"this":[65,234],"was":[67,174],"assess":[69],"effect":[72,209,218],"tolerability":[74],"low":[76,122],"doses":[77],"vulgaris":[85,106],"compare":[87],"high-dose":[90],"regimens.":[91],"Sixty-four":[92],"(35":[94],"women":[95],"29":[97],"men)":[98],"different":[100],"types":[101],"grades":[103],"were":[107,140],"divided":[108],"into":[109],"two":[110],"groups":[112],"32":[114],"patients,":[115],"trial":[118],"that":[119],"compared":[120],"dose":[123,132,151,178,227],"0.15-0.40":[125],"mg/kg":[126,135,182],"day":[128],"high":[131],"0.5-1.0":[134],"day.":[137],"These":[138],"regimens":[139],"analyzed":[141],"reference":[143],"clinical":[145,156],"history":[146],"baseline":[149],"investigations,":[150],"response":[153],"isotretinoin,":[155],"laboratory":[158],"adverse":[159,202],"effects,":[160],"relapses":[161,248],"cost":[163],"therapy.":[165],"mean":[167],"success":[168],"rate":[169,190],"schema":[173,199],"69%.":[175],"total":[177,226],"up":[179],"120":[181,231],"should":[183],"be":[184,242],"followed":[185],"optimal":[187],"results":[188,214],"(success":[189],"91%)":[192],"avoidance":[194],"relapses.":[196],"produced":[200],"fewer":[201],"effects":[203],"offered":[205],"very":[207],"beneficial":[208,217],"on":[210],"pre-existing":[211],"scarring.":[212,250],"Our":[213],"confirm":[215],"schema.":[222],"recommend":[224],">":[228],"or":[229],"=":[230],"mg/kg,":[232],"as":[233],"has":[239],"proven":[240],"most":[244],"successful":[245],"preventing":[247]},"counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}